Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
Clinical trial NCT01446042 · COMPLETED
Trial details
- NCT number
- NCT01446042
- Sponsor
- Acerus Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-12-01
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.